Raymond James & Associates’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $213K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $245K | Sell |
|
|||||
|
2022
Q4 | $223K | Sell |
|
|||||
|
2022
Q3 | $290K | Sell |
|
|||||
|
2022
Q2 | $302K | Sell |
|
|||||
|
2022
Q1 | $393K | Hold |
|
|||||
|
2021
Q4 | $540K | Hold |
|
|||||
|
2021
Q3 | $487K | Sell |
|
|||||
|
2021
Q2 | $481K | Sell |
|
|||||
|
2021
Q1 | $2.63M | Sell |
|
|||||
|
2020
Q4 | $2.6M | Sell |
|
|||||
|
2020
Q3 | $2.55M | Buy |
|
|||||
|
2020
Q2 | $2.01M | Buy |
|
|||||
|
2020
Q1 | $678K | Sell |
|
|||||
|
2019
Q4 | $1.08M | Sell |
|
|||||
|
2019
Q3 | $1.17M | Sell |
|
|||||
|
2019
Q2 | $1.41M | Buy |
|
|||||
|
2019
Q1 | $1.49M | Sell |
|
|||||
|
2018
Q4 | $1.88M | Sell |
|
|||||
|
2018
Q3 | $4.73M | Buy |
|
|||||
|
2018
Q2 | $3.37M | Buy |
|
|||||
|
2018
Q1 | $2.63M | Buy |
|
|||||
|
2017
Q4 | $1.3M | Buy |
|
|||||
|
2017
Q3 | $1.19M | Buy |
|
|||||
|
2017
Q2 | $1.05M | Buy |
|
|||||
|
2017
Q1 | $893K | Buy |
|
|||||
|
2016
Q4 | $819K | Buy |
|
|||||
|
2016
Q3 | $643K | Sell |
|
|||||
|
2016
Q2 | $1.29M | Buy |
|
|||||
|
2016
Q1 | $564K | Buy |
|